All In Biotech

Drug Trial Radar · NCT06057948

A Study of a Vaccine in Combination With Beta-glucan in People With Neuroblastoma

Phase II Trial of a Bivalent Vaccine With the Immunological Adjuvant OPT-821 (QS-21), in Combination With Randomization of Oral β-glucan, for High-Risk Neuroblastoma

Last checked: Nov 19, 2026Latest source record: Nov 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

100

Planned (sponsor's estimate)

Start

Sep 21, 2023

Primary completion

Mar 21, 2027

Study completion Mar 21, 2027

Sponsor

Lead sponsor
Memorial Sloan Kettering Cancer CenterAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Sep 28, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to test which treatment schedule of β-glucan with bivalent vaccine is more effective for participants with high-risk neuroblastoma that is in complete remission.

Conditions

  • Neuroblastoma
  • High-risk Neuroblastoma
  • Metastatic Neuroblastoma

Interventions

  • OPT-821 (QS-21)Biological

    Comprised of the immunological adjuvant OPT-821 (QS-21)

  • oral β-glucanDietary supplement

    Participants will be randomized to receive this agent in two different schedules

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Mean antibody titer in ng/ml of anti-GD2 IgG1 titerTime frame: up to 32 weeks

Locations

7 sites in 1 country. Site status is shown where the registry gives one.

  • Memorial Sloan Kettering at Basking Ridge (Consent only)

    Basking Ridge, New Jersey · Recruiting

  • Memorial Sloan Kettering Monmouth (Consent Only)

    Middletown, New Jersey · Recruiting

  • Memorial Sloan Kettering Bergen (Consent Only)

    Montvale, New Jersey · Recruiting

  • Memorial Sloan Kettering Suffolk-Commack (Consent only)

    Commack, New York · Recruiting

  • Memorial Sloan Kettering Westchester (Consent only)

    Harrison, New York · Recruiting

  • Memorial Sloan Kettering Cancer Center (All Protocol Activities)

    New York, New York · Recruiting

  • Memorial Sloan Kettering Nassau (Consent Only)

    Uniondale, New York · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.